Want to see ZOMDF full AI Analyst Report?
Zomedica (ZOMDF) Risk Analysis
Risk Overview Q2, 2026
Source: the company's latest filing for the period ended Jun 30, 2026, filed Aug 05, 2026
Risk Change Over Time
- Debt & Financing - Risk 1We may be required to make significant cash payments under our agreement with Brisby, which could impact our liquidity and require us to secure additional financing.
The Company may be required to make significant cash payments under the Brisby agreement, which could impact liquidity and financial flexibility. Under the terms of the Development and License Agreement with Brisby Inc., the Company was originally obligated to issue warrants upon achieving certain commercial milestones. However, since the Company's common stock is no longer listed on the NYSE American or an equivalent exchange, Brisby has the right to request cash payments in lieu of warrants. If these milestones are met, the Company may be required to pay up to $6.5 million in cash. These payments could materially impact the Company's liquidity, requiring the use of existing cash resources or necessitating additional financing. If the Company does not have sufficient available cash, it may need to seek external funding through equity or debt financing, which may not be available on favorable terms or at all. Failure to meet these obligations could result in penalties under the agreement or adversely affect the Company's business operations and financial condition. There is no assurance that the commercial milestones triggering these payments will occur, nor is there certainty regarding the timing of such obligations. However, if these payments become due, they may place a significant strain on the Company's financial resources.
Risk Highlights Q2, 2026
Risk Word Cloud
Risk Factors Full Breakdown - Total Risks 34
- Share Price & Shareholder Rights - Risk 1We are considered a smaller reporting company, and as such, are not required to provide the same level of information in our filings that a larger reporting company is. This reduction in the amount and depth of information could adversely affect investor insights and decision making.
We are a smaller reporting company as defined in the Exchange Act, and we will remain a smaller reporting company until the fiscal year following: -The determination that our voting and non-voting common stock held by non-affiliates is more than $250 million measured on the last business day of our second fiscal quarter; or -Our annual revenue is more than $100 million during the most recently completed fiscal year and our voting and non-voting common stock held by non-affiliates is more than $700 million measured on the last business day of our second fiscal quarter. Smaller reporting companies are able to provide simplified executive compensation disclosure and have certain other reduced disclosure obligations, including, among other things, being required to provide only two years of audited financial statements and not being required to provide selected financial data, supplemental financial information or risk factors. Further, as a non-accelerated filer, we will not be required to provide an auditor attestation of management's assessment of internal control over financial reporting, which is generally required for SEC reporting companies under Sarbanes-Oxley Act Section 404(b), and, in contrast to other reporting companies, we'll have more time to file our annual and periodic reports. We may choose to take advantage of the available exemptions for smaller reporting companies. We cannot predict whether investors will find our common stock less attractive if we rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our shares price may be more volatile.
- Share Price & Shareholder Rights - Risk 2We expect that the price of our common shares will fluctuate substantially.
The market price of our common shares has been subject to significant fluctuations, and we expect that the market price of our common shares will remain volatile. At times, the price of our common shares has changed significantly unrelated to any change in our financial condition or results of operations that would explain such a change. Numerous factors, including many over which we have no control, may have a significant impact on the market price of our common shares. Examples of these include: - any delays in, or suspension or failure of, any future studies;- delays in the commercialization of our existing or future products;- manufacturing and supply issues related to our existing or future products;- quarterly variations in our results of operations or those of our competitors;- changes in our earnings estimates or recommendations by securities analysts or adverse publicity about us or our product candidates;- announcements by us or our competitors of new products, significant contracts, commercial relationships, acquisitions or capital commitments;- announcements relating to future development or license agreements including termination of such agreements;- adverse developments with respect to our intellectual property rights or those of our principal collaborators;- commencement of litigation involving us or our competitors;- any major changes in our board of directors or management;- new legislation in the United States and abroad relating to our markets or our industry;- announcements of regulatory approval or disapproval of any of our future products or of regulatory actions affecting us or our industry;- product liability claims, other litigation or public concern about the safety of our existing or future products;- market conditions in the animal health industry, or in the sectors in which we participate, in particular, including performance of our competitors;- the impact of social media posts by third parties that may draw attention to our company and increase trading in our common shares by retail investors; and - general economic conditions in the United States and abroad. In addition, the stock market, in general, or the market for stocks in our industry may experience broad market fluctuations, which may adversely affect the market price or liquidity of our common shares. Any sudden decline in the market price of our common shares could trigger securities class-action lawsuits against us. If any of our shareholders were to bring such a lawsuit against us, we could incur substantial costs defending the lawsuit and the time and attention of our management would be diverted from our business and operations. We also could be subject to damages claims if we are found to be at fault in connection with a decline in our stock price.
- Share Price & Shareholder Rights - Risk 3Our Articles of Amalgamation (as amended) authorize us to issue an unlimited number of common shares and preferred shares without shareholder approval and we may issue additional equity securities or engage in other transactions that could dilute your ownership interest, which may adversely affect the market price of our common shares.
Our Articles of Amalgamation (as amended) authorize our Board of Directors, subject to the provisions of the Business Corporations Act (Alberta), or ABCA to issue an unlimited number of common shares and preferred shares without shareholder approval. Our Board of Directors may determine from time to time to raise additional capital by issuing common shares, preferred shares or other equity securities. We are not restricted from issuing additional securities, including securities that are convertible into or exchangeable for, or that represent the right to receive, common shares or preferred shares. Because our decision to issue securities in any future offering will depend on market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing, or nature of any future offerings, or the prices at which such offerings may be affected. Additional equity offerings may dilute the holdings of our existing shareholders or reduce the market price of our common shares, or both. Holders of our common shares are not entitled to pre-emptive rights or other protections against dilution. New investors also may have rights, preferences and privileges that are senior to, and that adversely affect, the then current holders of our common shares. Additionally, if we raise additional capital by making offerings of debt or preference shares, upon our liquidation, holders of our debt securities and preferred shares, and lenders with respect to other borrowings, may receive distributions of our available assets before the holders of our common shares.
- Share Price & Shareholder Rights - Risk 4Our Stock Appreciation Rights (SARs) liability may create volatility in our financial results, which could adversely affect investor confidence and our stock price.
Our Stock Appreciation Rights (SARs) Plan is classified as a liability under U.S. Generally Accepted Accounting Principles (GAAP) because SARs are settled solely in cash and do not result in the issuance of shares. As a liability-classified award, the fair value of the SARs is remeasured at each reporting date, and changes in fair value are recognized as compensation expense in our financial statements. The fair value of SARs is affected by various factors, including fluctuations in our stock price, stock price volatility, and other market-based assumptions. These periodic remeasurements may cause significant variability in our reported financial results from quarter to quarter, which could complicate comparisons of our financial performance across periods. This variability could adversely affect investor confidence, create uncertainty around our financial results, and negatively impact the market price of our common shares.
- Share Price & Shareholder Rights - Risk 5We have generated Canadian NOLs, but our ability to reserve and use these Canadian NOLs may be limited or impaired by future ownership changes.
Our ability to utilize the Canadian NOLs after a "loss restriction event" is subject to the rules of the Income Tax Act (Canada). A loss restriction event will occur if, among other things, there is change of control (which would generally occur if a person or group of related persons acquired more than 50% of our voting shares). If we experience a "loss restriction event": (i) we will be deemed to have a year-end for Canadian tax purposes and (ii) we will be deemed to realize any unrealized capital losses and our ability to utilize and carry forward Canadian NOLs will be restricted.
See a full breakdown of risk according to category and subcategory. The list starts with the category with the most risk. Click on subcategories to read relevant extracts from the most recent report.